OrthoPediatrics (FRA:2X7) FFO per Share

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:2X7 OrthoPediatrics Corp FRA:2X7
77 GF Score
Price €17.70
GF Value €31.63
! 5 Warning Signs
View Full Analysis

What is OrthoPediatrics FFO per Share?

FFO per Share only applies to REITs.

FRA:2X7
77GF Score
OrthoPediatrics Corp FRA:2X7
FFO per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is OrthoPediatrics (FRA:2X7) Overvalued in 2026?

Based on GuruFocus' analysis, OrthoPediatrics stock appears to be undervalued. The current stock price of €17.70 is trading 44% below its estimated GF Value™ of €31.63.

Key valuation signals for FRA:2X7:

  • FFO per Share:
  • GF Value™: €31.63 vs. price of €17.70 (44% below fair value)
  • GF Score™: 77/100 with 5 warning signs

No single metric tells the full story. See the FRA:2X7 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


OrthoPediatrics Business Description

Other Exchanges KIDS:USA
Address 2850 Frontier Drive, Warsaw, IN, USA, 46582
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.
77GF Score

Get the complete analysis for FRA:2X7

FFO per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€17.70
Price
€31.63
GF Value